News

News

Russia to seek approval for one-shot Sputnik Light in SA

14 Oct 2021

 

Business Dayreported on 14 October thatRussia will seek authorisation from SA Health Products Regulatory Authority (SAHPRA) for its single-shot Sputnik Light coronavirus vaccine after a study showed it is 70% effective at preventing transmission of the Delta variant three months after inoculation. Sputnik Light is the first component of the two-shot Sputnik V vaccine, developedby the Gamaleya National Research Centre of Epidemiology and Microbiology with backing from theRussian Direct Investment Fund (RDIF). It has been authorised as a stand-alone vaccine in more than 15countries, while Sputnik V has been approved in 70 countries. Russia has been struggling toget its vaccines approved by

the World Health Organisation, the US Food and Drug Administration and the European Medicines Agency
[BACK TO NEWS]